Weave’s cover photo
Weave

Weave

Pharmaceutical Manufacturing

San Francisco, CA 2,924 followers

The new standard in regulatory automation and lifecycle management

About us

Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Designed for pharma, biotechs, CROs, and consultants, the Weave Platform streamlines regulatory document preparation and lifecycle management by automating initial draft documents, extracting key insights, and integrating study data into a seamless, AI-enabled workflow. The platform accelerates regulatory processes, enabling faster drafting, high-quality reviews, and compliance with global standards. AutoIND, widely adopted for preclinical IND submissions, earned the “Biotech AI Innovation of the Year” award. And with AutoCT, Weave expanded capabilities into clinical-stage submissions, building the foundation for a singular AI workbench for the entire therapy lifecycle. Backed by top investors in AI and life sciences, Weave is creating a new AI-enabled, human-driven platform to enhance efficiency, submission quality, and cost-effectiveness. For more information, visit weave.bio. Interested in a career at Weave? Send your resume to joinourteam@weave.bio.

Website
https://www.weave.bio/
Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2023
Specialties
Regulatory document automation, Regulatory document preparation, Preclinical Document Authoring, Clinical Protocol Development, IND Authoring, Investigator’s Brochure (IB) Preparation, Clinical Study Report (CSR) Automation, Regulatory Strategy Alignment, AI-Assisted Medical Writing, eCTD-Ready Document Formatting, Clinical & Regulatory Lifecycle , Global Submission Readiness, Safety Narrative Compilation, and Automated Workflow for Regulatory Compliance

Locations

Employees at Weave

Updates

  • Weave reposted this

    View profile for ✟Wes Galliher, Ph.D.

    Outcomes-Obsessed Product Leader in B2B SaaS | Using Customer Data Insights to Help My Teams Build the Right Products, Faster

    Come join our growing team here at Weave !

  • 🔷 Weave Wednesday: Generate Your Clinical Protocols 🔷 With just a few source documents and less than 10 minutes ⌚ , you can use the Weave Platform to generate the protocol for your next clinical study. Our AI-powered baseline protocol template seamlessly incorporates your protocol synopsis and investigator's brochure to produce a draft in minutes. You can also reuse content from a previous protocol to drive efficiency and consistency across your clinical documents. 🎥 Ready to see it in action? Schedule at time at www.weave.bio #WeaveWednesday #ClinicalProtocol #WeavePlatform #RegOps #AIinBiotech #ProtocolAutomation #ClinicalDocs

  • We saw this gem of a post from Alex Zhavoronkov and couldn’t help but smile. Because honestly? We agree. A successful deal should come with something memorable, preferably weird and adorable. But let’s be real. The plush is just the symbol. What it really means? 👉 You helped bring a high-quality therapy to patients. 👉 You made smart, early moves that got a program into Phase I+. 👉 You and your team pulled off something that actually matters. At Weave, our platform helps the teams behind successful deals, from regulatory leads to cross-functional contributors, keep programs moving with the clarity, structure, and speed needed to deliver. So go ahead. Close the deal. Earn the plush. And props to every team — BD, regulatory, and beyond — that pushed it forward. #WeavePlatform #AIDrugDiscovery #RegulatoryReady

    My first executive order as the BD commander and chief: if you license an asset or do a sizable collaboration - key people on the deal team will get the memorable Labubu with the AI in Drug Discovery Scientist hoodie. If you don't know Labubu, check out the latest post by Joe Ngai. I know that other people will copy this idea but in this case, the fancy plush toy on your handbag will have much greater meaning. It means that you helped get a promising high-quality drug to patients in need. Getting novel medicine to patients faster, cheaper, with higher probability of success is our main objective function and we managed to set real industry benchmarks. All of the assets that we licensed out early are now in Phase I+ and doing well. Check out the link in the comments. #labubu #AIDrugDiscovery

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • View organization page for Weave

    2,924 followers

    𝗪𝗲𝗮𝘃𝗲 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆: 𝗔𝗜 𝗧𝗲𝗺𝗽𝗹𝗮𝘁𝗲𝘀 𝗠𝗮𝗱𝗲 𝗘𝗮𝘀𝘆! Using AI to craft regulatory documents doesn’t have to be complex. With 𝗔𝗜 𝗧𝗲𝗺𝗽𝗹𝗮𝘁𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗪𝗲𝗮𝘃𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺, it's as familiar and flexible as working in your favorite doc editor.  💡 𝗙𝗮𝗺𝗶𝗹𝗶𝗮𝗿 𝗙𝗼𝗿𝗺𝗮𝘁 Templates look like traditional documents with headings, body text, and clear blue AI instructions. No special syntax or coding required. 🪄 𝗦𝗺𝗮𝗿𝘁 𝗜𝗻𝘀𝗲𝗿𝘁𝗶𝗼𝗻 𝗧𝗼𝗼𝗹𝘀 Add AI-generated text, tables, variables, or standard text using a simple dropdown next to each section.  🔁 𝗗𝗿𝗮𝗴 𝗮𝗻𝗱 𝗗𝗿𝗼𝗽 𝗙𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆  Need to move a study summary or reorder sections? Just click and drag a paragraph, a table, or an entire section. ⚡ 𝗦𝗲𝗮𝗺𝗹𝗲𝘀𝘀 𝗧𝗼𝗴𝗴𝗹𝗲 Switch from content view to template mode in one click to fine-tune the instructions behind any AI-generated section. Your documents, your structure. AI just makes it faster.  👉 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝘁 𝘄𝗲𝗮𝘃𝗲.𝗯𝗶𝗼 #WeavePlatform #AITemplates #RegulatoryWriting #WeaveWednesday #AIinPharma

  • 🔬 Join Weave at the Cambridge Innovation Institute's BioProcessing Summit 📍 Booth #314 | 📅 August 19–22 | Boston, MA Upstream, downstream, and everything in between: bioprocessing drives innovation, and The Weave Platform helps make sure that innovation doesn’t get stuck in regulatory bottlenecks. Our AI-native cloud platform helps regulatory and technical teams tackle the most complex parts of submissions, especially CMC sections tied to process development and manufacturing. The result is less manual work, more consistency, and faster turnaround on critical documents. 💡 Live demos at the booth 🤝 Meet Daniel Pointing, Associate Director of Business Development 📅 Book a 1:1 in advance: https://lnkd.in/gt2UxBSQ Let’s talk about how regulatory work really flows. #WeaveBio #BioProcessingSummit #CMC #RegulatorySubmissions #AIinBiotech #RegulatoryWorkflows

    • No alternative text description for this image
  • 𝗪𝗲𝗮𝘃𝗲 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 – 𝗪𝗲’𝗿𝗲 𝗛𝗶𝗿𝗶𝗻𝗴! This one’s for the AI evangelists who are equal parts engineer, educator, and product consultant. 🚀 Weave is hiring our first 𝗔𝗜 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁—someone to help life sciences teams scale LLM-powered tools to generate high-quality scientific and regulatory content faster than ever. If you're passionate about improving drug development with AI, love educating customers, and want your ideas to shape the product—let’s talk. 🛠️ What you’ll do: • Customize “AI Templates” for submission-ready content that reflects each customer’s science and style • Teach teams how to adapt and manage their own templates • Document best practices • Collaborate with product and commercial teams to bring AI into real-world pipelines 🧩 You might be our missing piece if: • You’re fluent in prompting LLMs and getting results • You’ve worked in biotech, CRO, or CDMO—INDs, NDAs, and CMCs are familiar territory • You love teaching and are comfortable in early-stage, fast-moving environments 💎 Remote. Full-time. Want to help shape how AI is applied in one of the world’s most regulated industries? Apply now 👉 https://lnkd.in/g5PgE7XT #WeaveWednesday #Hiring #AIJobs #LLMs #LifeSciences #MLForGood #DrugDevelopment #WeaveBio #AIPrompt #AITemplate #AIImplementations #RegulatorySubmission

  • View organization page for Weave

    2,924 followers

    ✍️ At Weave, we define a writer as someone who brings scientific precision, clarity, and intention to work that directly impacts patients. That’s why this question from the The Nobel Prize resonated with us today: “What’s your definition of a writer?” Regulatory writers might not make headlines—but their work moves science forward. They translate complex data into submissions that are scrutinized, reviewed, and relied on to bring therapies to the people who need them most. 🧬 At Weave, we build AI-native tools to support that mission—not to replace the human writer, but to amplify them. Because in regulatory writing, it’s not just what you say—it’s how clearly, accurately, and precisely you present the data.💡 #RegulatoryWriting #WritersOfScience #NobelInspiration #HumanCenteredAI #Weave #AIinPharma

    View organization page for The Nobel Prize

    1,072,001 followers

    What is your definition of a writer? "All good books are alike in that they are truer than if they had really happened and after you are finished reading one you will feel that all that happened to you and afterwards it all belongs to you: the good and the bad, the ecstasy, the remorse and sorrow, the people and the places and how the weather was. If you can get so that you can give that to people, then you are a writer." - Nobel Prize laureate Ernest Hemingway's definition of a writer. #NobelPrize

    • Ernest Hemingway sitting at a cluttered desk covered with books and papers, interacting with a cat in a cozy room lined with bookshelves.
    • Ernest Hemingway sitting casually in a white wooden chair outdoors, surrounded by lush greenery, holding a book with papers on a table beside him.
    • Ernest Hemingway reading in a cozy room, illuminated by a table lamp, with two glasses on a side table.
    • Ernest Hemingway sitting on steps outside his home, holding a cat.
  • View organization page for Weave

    2,924 followers

    𝗧𝗵𝗶𝘀 𝗰𝗮𝘂𝗴𝗵𝘁 𝗼𝘂𝗿 𝗮𝘁𝘁𝗲𝗻𝘁𝗶𝗼𝗻—𝗮𝗻 𝗔𝗜-𝗲𝗻𝗮𝗯𝗹𝗲𝗱 𝘁𝗼𝗼𝗹 𝗻𝗼𝘄 𝗙𝗗𝗔-𝗰𝗹𝗲𝗮𝗿𝗲𝗱 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝘀𝘂𝗿𝗴𝗲𝗼𝗻𝘀: SimBioSys just received its third FDA clearance for 𝗧𝘂𝗺𝗼𝗿𝗦𝗶𝗴𝗵𝘁 𝗩𝗶𝘇 1.3, a platform that uses AI to transform standard breast MRIs into detailed 3D visualizations to assist with surgical planning. 🔍 𝗪𝗵𝘆 𝗶𝘁’𝘀 𝗻𝗼𝘁𝗮𝗯𝗹𝗲: • Applies advanced imaging and AI to support more precise excision • Aims to reduce reoperations and preserve healthy tissue • Reflects a broader trend: AI-powered tools earning regulatory validation through clinical performance At Weave, we’re encouraged to see AI thoughtfully integrated into solutions that help clinicians make confident, timely decisions. It’s another example of how 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, 𝘄𝗵𝗲𝗻 𝗮𝗹𝗶𝗴𝗻𝗲𝗱 𝘄𝗶𝘁𝗵 𝗿𝗲𝗮𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗻𝗲𝗲𝗱 𝗮𝗻𝗱 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲𝗱 𝗿𝗶𝗴𝗼𝗿𝗼𝘂𝘀𝗹𝘆, 𝗰𝗮𝗻 𝗲𝗻𝗵𝗮𝗻𝗰𝗲 𝗰𝗮𝗿𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆. 📖 Read the full article: https://lnkd.in/gBt9K8fA #𝗠𝗲𝗱𝗧𝗲𝗰𝗵 #𝗕𝗿𝗲𝗮𝘀𝘁𝗖𝗮𝗻𝗰𝗲𝗿  #𝗔𝗜𝗶𝗻𝗛𝗲𝗮𝗹𝘁𝗵 #𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆𝗠𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲  #𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 #𝗙𝗗𝗔 #𝗗𝗶𝗴𝗶𝘁𝗮𝗹𝗛𝗲𝗮𝗹𝘁𝗵

  • 🔹 Weave Wednesday 🔹 𝗪𝗵𝗮𝘁 𝗶𝗳 𝗰𝗿𝗲𝗮𝘁𝗶𝗻𝗴 𝗮 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗦𝘁𝘂𝗱𝘆 𝗥𝗲𝗽𝗼𝗿𝘁 𝗱𝗶𝗱𝗻’𝘁 𝘁𝗮𝗸𝗲 𝗱𝗮𝘆𝘀—𝗼𝗿 𝘄𝗲𝗲𝗸𝘀? 💡 𝗪𝗶𝘁𝗵 𝗧𝗵𝗲 𝗪𝗲𝗮𝘃𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺, 𝗶𝘁 𝗰𝗮𝗻 𝘁𝗮𝗸𝗲 𝗷𝘂𝘀𝘁 𝗼𝗻𝗲 𝗵𝗼𝘂𝗿. We’re showing how structured data and human-driven automation come together to accelerate regulatory workflows—without cutting corners. Watch how it works—and imagine reclaiming time for what really matters. 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗮 𝗰𝘂𝘀𝘁𝗼𝗺 𝗱𝗲𝗺𝗼? 𝗕𝗼𝗼𝗸 𝗵𝗲𝗿𝗲: https://lnkd.in/gPyMW4mQ #WeaveWednesday #ClinicalStudyReport #RegulatoryWorkflows #Biotech #Pharma #AutoIND #WeavePlatform

  • 🧠 From Time-Lapse to Top 20 Insights—Watch the Regulatory Affairs Professionals Society (RAPS) Webinar On Demand In this RAPS educational webinar, we showcase a real-time, time-lapse demo of a CSR build using the Weave Platform—turning weeks of work into minutes. We also share final results from a collaboration with a Top 20 pharma company, comparing AI-assisted and traditionally authored IND content across time, quality, and output. 🎥 Catch the replay → https://hubs.ly/Q03wmM4w0 #RAPS #WeavePlatform #RegOps #ConnectedDossiers #AIinRegulatory #Top20Pharma

    • No alternative text description for this image

Similar pages

Browse jobs